Roche Diagnostics Corp. and bioMerieux SA are joining the growing list of in vitro diagnostics makers addressing the COVID-19 pandemic.
On 13 March, Roche announced that the US Food and Drug Administration issued an Emergency Use Authorization (EUA) for its test for SARS-CoV-2, the virus that causes COVID-19 disease.